➖ On the 26-Dec session we have an inverted hammer candlestick pattern to signal the top of a trend.
This inverted hammer is followed by four weeks red; Inverted hammer as reversal signal confirmed.
ARKK produced an upper wick this week, now trades red.
➖ The action moved below EMA100, mid-term bearish potential confirmed.
Multiple bearish signals confirmed. We can expect lower for this ETF, easily.
Namaste.
This inverted hammer is followed by four weeks red; Inverted hammer as reversal signal confirmed.
ARKK produced an upper wick this week, now trades red.
➖ The action moved below EMA100, mid-term bearish potential confirmed.
Multiple bearish signals confirmed. We can expect lower for this ETF, easily.
Namaste.
Note
Here we have a rejection at resistance; in this case EMA100: This rejection is a bearish confirmation.
We can expect to see this ETF move lower as it has been happening already for weeks.
🚨 TOP FREE Trades
ETH +1700% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1700% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 TOP FREE Trades
ETH +1700% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1700% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.